Normostop (Dimenhydrinate)

Dimenhydrinate blocks histamine H1 receptors in the brain’s vestibular system and the vomiting centre, which reduces the signal that triggers nausea. Its anticholinergic activity also dampens central pathways involved in emesis, providing relief from motion‑related and other types of nausea.

The appropriate dose of Normostop is determined by a qualified prescriber based on the patient’s age, weight, medical condition and response to therapy. Healthcare professionals tailor the regimen to achieve optimal symptom control while minimizing potential side effects.

Safety data for dimenhydrinate in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Normostop.

To request Normostop, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Normostop (dimenhydrinate) is a first‑generation antihistamine, whereas alternatives such as meclizine or scopolamine belong to different classes. Dimenhydrinate offers rapid onset and is widely available OTC, but it may cause more drowsiness compared with newer agents. Choice of therapy depends on efficacy, side‑effect profile and individual patient factors.

Normostop should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain its stability and potency throughout its shelf life.

Normostop is taken orally, usually as a tablet, with or without food as directed by a healthcare professional. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious adverse reactions, although rare, can include severe allergic responses such as rash, swelling, or anaphylaxis, as well as tachycardia, marked hypotension, confusion, urinary retention, and profound sedation. Patients should seek immediate medical attention if any of these symptoms develop.

Normostop should not be used by individuals with known hypersensitivity to dimenhydrinate or other first‑generation antihistamines. Caution is advised for patients with glaucoma, enlarged prostate, severe asthma, or those taking other anticholinergic or sedating medications. Pregnant or breastfeeding women should consult a physician before use.